State of Wisconsin Investment Board’s Protalix BioTherapeutics PLX Stock Holding History

State of Wisconsin Investment Board’s Portfolio PLX Stock Details PLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-25,950	Closed	-$265K	–	1323
2015 Q4	$265K	Hold	25,950	–	–	﹤0.01%	1297
2015 Q3	$306K	Hold	25,950	–	–	﹤0.01%	1314
2015 Q2	$506K	Hold	25,950	–	–	﹤0.01%	1310
2015 Q1	$462K	Hold	25,950	–	–	﹤0.01%	1301
2014 Q4	$477K	Sell	25,950 -14,980	-37%	-$322K	﹤0.01%	1297
2014 Q3	$991K	Sell	40,930 -4,070	-9%	-$117K	﹤0.01%	1269
2014 Q2	$1.64M	Hold	45,000	–	–	0.01%	1231
2014 Q1	$2.06M	Hold	45,000	–	–	0.01%	1128
2013 Q4	$1.75M	Hold	45,000	–	–	0.01%	1164
2013 Q3	$2.04M	Buy	45,000 +25,000	+125%	+$1.28M	0.01%	1097
2013 Q2	$982K	Buy	+20,000	New	+$1.06M	﹤0.01%	1228

Other funds holding PLX

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

State of Wisconsin Investment Board's PLX Position: Q1 2016 in Review

State of Wisconsin Investment Board sold out of Protalix BioTherapeutics (PLX) in Q1 2016, closing a stake of 25,950 shares — an estimated $265K sold.

State of Wisconsin Investment Board first reported a position in PLX in Q2 2013 and held it in 11 quarters. The position peaked at $2.06M in Q1 2014. 33 funds tracked by Wall St. Rank hold PLX as of Q1 2016.

State of Wisconsin Investment Board reported no remaining Protalix BioTherapeutics position as of Q1 2016 after selling out during the quarter.
State of Wisconsin Investment Board sold 25,950 Protalix BioTherapeutics shares in Q1 2016, an estimated $265K.
State of Wisconsin Investment Board first reported a position in Protalix BioTherapeutics in Q2 2013 and held it in 11 quarters.
State of Wisconsin Investment Board's Protalix BioTherapeutics position peaked at $2.06M in Q1 2014.
33 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2016.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2016, filed 4 May 2016.